A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants
Clinical trial NCT03990519 · COMPLETED
Trial details
- NCT number
- NCT03990519
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2020-02-19
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.